The table below shows RAPT Therapeutics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Q1 2020
Operating cash flow
-$52.41M
-$27.08M
-$18.60M
-$15.58M
-$13.91M
-$8.74M
Capital expenditure
$43.00K
$105.00K
$759.00K
$149.00K
$227.00K
$98.00K
Investing cash flow
-$57.06M
$15.89M
$25.31M
$23.84M
$12.41M
-$46.98M
Dividends paid
-
-
-
-
RAPT operating cash flow (10-K history)
RAPT Therapeutics, Inc. reported operating cash flow of -$83.30M for fiscal year 2024. That is up 14.2% from -$97.05M in fiscal 2023. Over the 7 fiscal years shown, operating cash flow declined from -$32.95M (FY 2018) to -$83.30M. Figures come from the company's audited annual reports as filed with the SEC.